Enliven Therapeutics increased its research and development spending in the fourth quarter of fiscal 2024 as several drug ...
Gogo boosted its year-over-year sales significantly in the fourth quarter of 2024 — a period in which Gogo acquired Satcom Direct — but posted a net loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback